Cyclic peptides for treatment for cachexia
US7342089B2 · kind B2 · utility
17Cited by
15References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 5, 2005 |
| Grant date | Mar 11, 2008 |
| Priority date | — |
| Expiry date | Jul 5, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/811
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A highly selective melanocortin-4 receptor antagonist cyclic peptide of the formulawhere R1, R2, R3, R4a, R4b, R5, R6, R7, x, y and z are as defined in the specification, and a method of treating body weight disorders, including cachexia, sarcopenia and wasting syndrome or disease, and treating inflammation and immune disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.